Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. [electronic resource]
Producer: 19930514Description: 15-21 p. digitalISSN:- 0001-5792
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Child
- Cytarabine -- administration & dosage
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Metaphase
- Middle Aged
- Polymerase Chain Reaction
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.